Applicants are invited to apply for the Making More Health Accelerator 2019 that supports social entrepreneurs with well-established startups in the health space with an opportunity to strengthen and scale their work via the reach and operations of a multinational healthcare company through co-creation.
Since 2011, Ashoka – one of the world’s largest networks of social entrepreneurs and Boehringer Ingelheim, a family-owned world leading and research-driven Pharmaceutical company, have collaborated to create and grow the global initiative, Making More Health (MMH).
Making More Health brings together the best experience in social innovation and global healthcare to improve health-care access for people, animals and their communities around the world.
The MMH Accelerator is a structured, 11-month business accelerator program. Through the MMH Accelerator, participants are provided with tailored access to expertise and capacity building to unlock their next phase of growth. A unique feature of the program is its co-creation approach – which involves participating social entrepreneurs working hand-in-hand with Boehringer Ingelheim employees to collaboratively design and implement relevant interventions. At the end of the accelerator, social entrepreneurs with successful interventions will have the opportunity to present their solutions to Boehringer Ingelheim’s leadership team as well as social investors to attract further investment.
- Trainings (both virtual and in-person) on business growth and scaling strategies, investor engagement and pitching, tailored to the strategic needs of their organization.
- Access to technical expertise (in-person) in finance, strategy, operations, information technology, marketing and social investing among others to help address strategic capacity gaps specific to their organization.
- Access to strategic networks including: social investors, leading social entrepreneurs in the health care space and executive team members from Boehringer Ingelheim and Ashoka.
- Funding of up to Euros 50k in cash plus additional in-kind expertise valued at Euros 100k.
- Investor engagement support including preparation of investor engagement materials and facilitated access to investors.
Social entrepreneurs with well-established startups in the human (non- communicable diseases) or animal health space are encouraged to apply, if their organizations meet the following criteria:
- Late stage startups (at least two years old) in human health (non-communicable diseases) or animal health.
- Fully registered legal entity that is at least two years old.
- Post revenue with a product, customers and sales.
- Established with an office, team, basic systems and processes in place.
- Operating in Kenya, Ghana or Nigeria.
- Open to work with a pharmaceutical company such as Boehringer Ingelheim in a co-creation approach.
- Capacity to dedicate a full-time resource(s) to execute MMH Accelerator activities.
- Potential to create shared-value through co-creation
- Disruptive potential of innovation
- Strategic fit for Boehringer Ingelheim
Dateline for submission: 15 February 2019
Illustration Photo: The drone delivery project is a partnership between the Government of Rwanda and the California based robotics company, Zipline, Inc. With the help of these drones, patients no longer have to wait for blood for hours to get to remote clinics and hospitals. They can now receive blood transfusions in minutes. (credits: Sarah Farhat / World Bank / Flickr Creative Commons Attribution-NonCommercial-NoDerivs 2.0 Generic (CC BY-NC-ND 2.0))